News

An emphasis on collecting and assessing quality-of-life biomarkers shows promise for tailoring treatment of the rare condition.

Though weekly activity has slowed, experts insist the national activity remains high overall.

Younger hepatitis B patients had better odds at transplant-free survival after 6 months.

A new study examines how different types of chronic conditions were associated with different increases in risk of visual impairment.

Cerebrospinal fluid storage time did not influence the tested biomarker levels in narcolepsy type 1 patients.

A discussion on how to approach the real-world application of bempedoic acid with the Chief of Cardiology at Baylor College of Medicine.

New data shows that baseline severity of depression did not moderate the variability of responses to antidepressants.

The approval is the second non-statin LDL-C lowering therapy from Esperion to receive approval in the month of February.

What is the primary care physician's role in detecting the rare hepatologic condition?

A new algorithm using a 70% training had a 51.7% success rate in predicting individualized treatments for first-episode schizophrenia patients.

Early menopause onset has been linked to increased CVD risk, but a new study from England is examining whether age of onset has a role in worsening risk factors.

A clinical health psychologist discusses how to keep a patient-centered approach for treating chronic pain in today's healthcare environment.

Young mothers are 2-4 times more likely to have an anxiety disorder than both young women without children and older mothers.

The approval allows Zynex to market CM-1500, a blood monitoring system aimed at helping doctors monitor various patient parameters.

The VistaScan mobile ultrasound platform from Emagine Solutions Technology can be used via an app and connect directly to a clinician's cell phone or tablet.

Investigators find intensive behavior therapy results in weight loss, even in the placebo-controlled group.

The Ready, Set, Food! co-founder discusses how research and federal advisory shapes parental understanding of immunotherapy and food allergy prevention.

Results of the LINK-HF study indicate a wearable sensors from Vital Connect combined with a predictive algorithm can predict HF exacerbations.

The FDA announced the first approval of ProAir HFA—1 of the most popular inhalers in the US market.

A fourth-year medical student discusses strategies for anticoagulation reversal in intensive care units from a presentation during the 49th Annual Critical Care Congress in Orlando.

New data from a study of 30 patients found specific characteristics of gut microbiota could predict the presence of pulmonary hypertension with greater than 80% accuracy.

The FDA has approved a quadrivalent formula of the adjuvanted seasonal influenza vaccine from Seqiris.

With approval, the GLP-1 receptor agonist becomes the first diabetes drug approved for reducing MACE in patients with and without established cardiovascular.

A military service member talks about some of the ways the Navy is implementing new programs to improve mental health conditions.

Early psychosis patients experienced better social functioning after cognitive behavior therapy.

As symptoms reportedly reach the majority of the US physician population, it's time to discuss individual strategy to reduce the risk and effect of burnout.

Patients express worry related to using opioids and that they are not always on the same page as their provider.

How can primary care and family physicians help put concerned patients at ease?